6[2]Muller RH,Mader K,Gohla S.Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art[J].Eur J Pharm Biopharm,2000,50(1):161 被引量：1
7[3]Hashida M,Nishikawa M,Takakura Y.Hepatic targeting of drugs and proteins by chemical modification[J].J Controlled Release,1995,36(1/2):99 被引量：1
8[4]Muller RH,Mehnert W,Lucks JS.Solid lipid nanoparticles (SLN)- an alternative colloidal carrier system for controlled drug delivery [J].Eur J Pharm Biopharm,1995,41:62 被引量：1
9[5]Muller RH,Maassen S,Schwarz C.Solid lipid nanoparticles(SLN) as potential carrier for human use: interaction with human granulocytes[J].J Control Release,1997,47:261 被引量：1
10[6]Muller RH,Ruhl D,Runge S,et al.Mehnert W.Cytotoxicity of Solid lipid nanoparticles as a function of the lipid matrix and the surfactant [J].Pharm Res,1997,14:458 被引量：1
